Calls for papers
-
Satsuma Pharmaceuticals announced that it has initiated the Phase 3 EMERGE trial of STS101 dihydroergotamine (DHE) nasal powder for the acute treatment of migraine. In April 2019, Satsuma announced that it had raised $62 million… Read more . . .
-
Pneuma Respiratory, which is developing a digital soft mist inhaler, has announced the appointment of Jay Morgan as Chairman of the Board. Morgan, a former Bayer and Merck executive who has been a member of the board… Read more . . .
-
Hikma Pharmaceuticals has agreed to acquire two nasal sprays as well as unit-dose nasal spray manufacturing assets from Insys Therapeutics, the company said. In June 2019, Insys declared bankruptcy and said that it would sell… Read more . . .
-
Perrigo announced that it has settled a lawsuit filed by Endo Pharmaceuticals in May 2019 that alleged infringement of patents related to Nascobal cyanocobalamin nasal spray which expire in 2024. The terms of the settlement… Read more . . .
-
Third Pole Therapeutics said that it has received two new patents from the US Patent and Trademark Office covering its inhaled nitric oxide (iNO) delivery systems through at least 2038. The patents (No. 10,286,176 and… Read more . . .
-
Inhaler monitoring company Adherium said that it has signed a deal with Summatix (formerly Charm Informatics) to allow data from Adherium’s Hailie connected inhaler sensors to be accessed through the Summatix medical data platform. Adherium… Read more . . .
-
The United States Patent and Trademark Office has granted US patent No. 10376465 (“Monovalent Metal Cation Dry Powders for Inhalation”) to Pulmatrix, the company said. The claims cover formulations of Pulmazole inhaled dry powder itraconazole,… Read more . . .
-
Circassia Pharmaceuticals has announced the appointment of Jonathan Emms as Chief Operating Officer and as an Executive Director of the Board of Directors. Emms previously served in a number of executive roles at Pfizer, most… Read more . . .
-
Proveris Scientific has announced an expansion of its Americas and Asia Pacific customer service support team with the hire of Doug Mann as a Field Service Engineer. The company also recently added Stephen McDonald to… Read more . . .
-
According to generic inhalation device developer Merxin, the FDA has reviewed data for the company’s MRX001 blister multidose DPI and suggested that the agency would accept the MRX001 as an AB rated substitutable version of… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA